No more than 15 authors can be listed.Please ensure the authors are listed in the right order.If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.
Capillary blood gas (CBG) testing is a minimally invasive alternative to arterial blood gas (ABG) sampling. To enhance patient comfort and reduce disruption to physicians' clinic flow, a nurse-led CBG service was introduced at our institution in May 2023.
All tests were performed using fingertip capillary sampling by trained nurses, via a calibrated iSTAT 300 point-of-care equipment (Abbott Laboratories, USA). Device measurements were separately validated using laboratory equipment (R2 values 0.98 and 0.99 for pH and pCO2 respectively). We evaluated service uptake and safety outcomes from 2023 to 2025. An additional clinical audit of 100 randomly selected cases in 2025 examined referral patterns, demographics, clinical indications, and concordance with ABG results where available.
CBG adoption increased rapidly accouting for 179 tests (64% of all blood gases) in 2023, 460 (95%) in 2024, and 540 (97%) in 2025. In the 2025 audit, 80% of referrals were made by consultants. All samples were successfully collected with no complications. One-third of cases had elevated pCO2No ABG was performed in the same clinic session. Two patients had ABG during same day admission for fluid overload and results were concordant with prior CBG findings. Patients were predominantly male (61%) and of Chinese ethnicity (74%). The main indications for CBG were sleep-disordered breathing evaluation (42%), monitoring patients on non-invasive ventilation (17%), and COPD follow up (13%). Half of the patients had underlying lung disease and 59% had suspected or confirmed obstructive sleep apnoea.
Within two years, the nurse-led CBG service achieved near-universal uptake in an outpatient setting with excellent feasibility and safety. Combined with pulse oximetry, CBG appeared to replace the need for ABG in most instances. CBG should be considered a reliable and scalablle alternative to ABG in routine respiratory outpatient practice.